Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid versus placebo for blood loss reduction in abdominal myomectomy
PACTR202410528859448Not yet recruiting
- Sponsor
- Esan Babatunde Ayodeji
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Fibromyoma (LM) comparing Tranexamic acid group with Placebo group (2 arms). Primary endpoint: Total blood loss at surgery. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202410528859448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202410528859448.